---
title: "Beam Therapeutics (BEAM.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BEAM.US/norm.md"
symbol: "BEAM.US"
name: "Beam Therapeutics"
parent: "https://longbridge.com/en/quote/BEAM.US.md"
datetime: "2026-05-21T09:15:03.696Z"
locales:
  - [en](https://longbridge.com/en/quote/BEAM.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BEAM.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BEAM.US/norm.md)
---

# Beam Therapeutics (BEAM.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.9134 | 2.33 | -1.10 | -1.00 | -1.23 |
| ROE | -31.40% | 88.66% | -44.80% | -37.71% | -46.68% |
| Revenue | 31.74M | 114.11M | 9.70M | 8.47M | 7.47M |
| Net income | -94.32M | 244.30M | -112.73M | -102.29M | -108.33M |
| Operating income | -107.22M | -17.45M | -126.81M | -120.15M | -119.29M |
| Gross margin | 65.16% | 13.00% | -1031.87% | -1101.96% | -110.62% |
| Net margin | -297.18% | 214.09% | -1162.38% | -1208.26% | -1450.20% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.48B | 1.48B | 1.31B | 1.39B | 1.47B |
| Leverage | 1.27 | 1.20 | 1.36 | 1.33 | 1.31 |
| BVPS | 11.71 | 12.48 | 9.80 | 10.70 | 11.52 |
| Turnover | 0.1113 | 0.1081 | 0.0449 | 0.0454 | 0.0450 |
| Cash & STI | 1.21B | 1.25B | 1.07B | 1.15B | 1.22B |
| Inv & Rec | - | - | - | - | - |
| LT assets | 199.40M | 205.18M | 205.28M | 208.39M | 211.78M |
| Net debt | -960.83M | -1.09B | -923.55M | -995.53M | -1.06B |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -128.51M | -83.29M | -81.48M | -76.45M | -103.88M |
| Investing CF | 25.27M | 108.41M | 65.66M | -170.41M | -125.09M |
| Financing CF | 96.61M | 1.89M | 1.68M | 1.11M | 473.38M |
| Free CF | -99.20M | -75.72M | -45.72M | -12.94M | -85.92M |
| OCF coverage | -5757.75% | -2230.56% | -1626.00% | -2437.82% | -3389.36% |
| Repaid & issued | 93.89M | - | - | - | - |
| CapEx | -2.23M | -3.73M | -5.01M | -3.14M | -3.06M |